← All stories
Markets
Nxera to receive $10m milestone as partner’s Alzheimer’s drug enters phase 2
Covered by 1 outlet
All coverage · 3 articles
Investing.com Canada
·2h ago
Nxera to receive $10m milestone as partner’s Alzheimer’s drug enters phase 2
Investing.com UK
·2h ago
Nxera to receive $10m milestone as partner’s Alzheimer’s drug enters phase 2
Investing.com News
·2h ago